Sections
| Title | Starting Page | Number of Pages |
|---|
| NPAT accelerates as operating leverage comes to the fore | 1 | 1 |
| Business model | 1 | 1 |
| Better-than-forecast cash generation after funding growth | 1 | 1 |
| Base-case DCF valuation of $0.12/share, fully diluted | 1 | 1 |
| Table/Chart: Earnings history and RaaS’ estimates (in A $m unless otherwise stated) | 1 | 1 |
| Graph: Share Performance (12 months) | 1 | 1 |
| Upside Case | 1 | 1 |
| Downside Case | 1 | 1 |
| Table/Chart: Board and Management | 1 | 1 |
| Table/Chart: Company Contacts | 1 | 1 |
| Table/Chart: RaaS Contact | 1 | 1 |
| Disclosure | 1 | 1 |
| FY26 Result Analysis | 2 | 1 |
| Table/Chart: Exhibit 1: Key figures from FY26 financial statements (in A $m unless otherwise stated) | 2 | 1 |
| Table/Chart: Exhibit 2: FY26 P&L vs. FY25 and RaaS FY26 forecasts (in A $m unless otherwise stated) | 2 | 1 |
| Table/Chart: Exhibit 3: Sales revenue by division, EBITDA and margin (in A $m unless otherwise stated) | 3 | 1 |
| Graph: Exhibit 4: Five-year transformation to profitability | 3 | 1 |
| Earnings Adjustment | 3 | 1 |
| Table/Chart: Exhibit 5: Earnings adjustments (in A $m unless otherwise stated) | 3 | 1 |
| Base-Case DCF Valuation Is $0.12/Share Fully Diluted | 4 | 1 |
| Table/Chart: Exhibit 6: Base-case DCF valuation | 4 | 1 |
| Table/Chart: Exhibit 7: Financial Summary | 5 | 1 |
| FINANCIAL SERVICES GUIDE | 6 | 1 |
| RaaS Research Group Pty Ltd | 6 | 1 |
| Corporate Authorised Representative, number 1248415, of | 6 | 1 |
| About Us | 6 | 1 |
| Our general advice service | 6 | 1 |
| How are we paid? | 6 | 1 |
| Associations and Relationships | 6 | 1 |
| Complaints | 6 | 1 |
| Professional Indemnity Insurance | 6 | 1 |
| Disclosure | 7 | 1 |
